TaqMan

Exome sequences from thousands of Chinese individuals with or without esophageal squamous cell carcinoma led to six new germline risk variants.

Roughly one-fifth of adult cases of acute lymphoblastic leukemia are marked by Philadelphia chromosome-like expression. 

Researchers in Belgium and the UK showed that their custom viral panel on Thermo Fisher's TaqMan qPCR array card is effective in samples from immunocompromised patients.

The assays add to the test menu of Beckman Coulter's DxN Veris molecular diagnostics system.

The strategy could be applied more widely to study the development of other organ systems, and will benefit from new single-cell gene expression analysis technology.

Thermo Fisher Scientific this week announced the release of the QuantStudio 3D Rare Mutation Analysis solution.

NEW YORK (GenomeWeb) – Roche today announced the launch of the Global Access Program for HIV viral load testing.

Life Technologies, a Thermo Fisher Scientific brand, said this week that it has launched TaqMan multiplex reagents.

Scientists from the Stanford University School of Medicine and the Stanford Genome Technology Center have demonstrated proof of principle for performing high-sensitivity detection and quantification of DNA copy number and SNPs on Bio-Rad's droplet digital PCR platform using a sin

NEW YORK (GenomeWeb News) – Copy number and expression shifts involving cytokine immune genes in colorectal cancer samples can offer insights into immune involvement in the disease and its propensity for progression, a new study suggests.

Pages

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The Associated Press reports that gene-edited food may soon be for sale.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.